Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer
Despite major medical advances in recent decades, colorectal cancer remains a major public health problem with significant unmet medical needs. This reprint presents new scientific and clinical data, and discusses the need to identify new theranostic biomarkers from tissue and fluid biopsies, to go...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_98158 | ||
005 | 20230307 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230307s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-6836-2 | ||
020 | |a 9783036568379 | ||
020 | |a 9783036568362 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-6836-2 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a K |2 bicssc | |
100 | 1 | |a Dedieu, Stephane |4 edt | |
700 | 1 | |a Dedieu, Stephane |4 oth | |
245 | 1 | 0 | |a Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (206 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Despite major medical advances in recent decades, colorectal cancer remains a major public health problem with significant unmet medical needs. This reprint presents new scientific and clinical data, and discusses the need to identify new theranostic biomarkers from tissue and fluid biopsies, to go further in terms of personalised medicine and thus overcome current limitations. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Economics, finance, business & management |2 bicssc | |
653 | |a Snail transcription factor | ||
653 | |a extracellular vesicles | ||
653 | |a colon cancer | ||
653 | |a pre-metastatic niche | ||
653 | |a PD-L1 | ||
653 | |a CMS | ||
653 | |a RAS mutations | ||
653 | |a colorectal cancer | ||
653 | |a liver metastases | ||
653 | |a surgery | ||
653 | |a resection | ||
653 | |a ablation | ||
653 | |a discoidin domain receptor | ||
653 | |a prognosis | ||
653 | |a event free survival | ||
653 | |a survival | ||
653 | |a chemokine | ||
653 | |a ACKR3 | ||
653 | |a metastasis | ||
653 | |a microenvironment | ||
653 | |a signaling pathways | ||
653 | |a epigenetics | ||
653 | |a therapy | ||
653 | |a resistance | ||
653 | |a lung metastases | ||
653 | |a protein biomarker | ||
653 | |a dual expression | ||
653 | |a early recurrence | ||
653 | |a poor prognosis | ||
653 | |a precision medicine | ||
653 | |a ERBB2 | ||
653 | |a HER-2 | ||
653 | |a Lynch Syndrome | ||
653 | |a mismatch repair proteins | ||
653 | |a genome-wide association study | ||
653 | |a Mendelian randomization | ||
653 | |a polygenic risk scores | ||
653 | |a liquid biopsy | ||
653 | |a rare cell | ||
653 | |a circulating tumor cells | ||
653 | |a oncosomes | ||
653 | |a heterogeneity | ||
653 | |a multi-assay | ||
653 | |a high-definition single-cell assay | ||
653 | |a colonic neoplasms | ||
653 | |a chemotherapy | ||
653 | |a adjuvant | ||
653 | |a tumor budding | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6931 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/98158 |7 0 |z DOAB: description of the publication |